Welcome to Flow Pharma Inc.

Page Loading...


Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

Flow Pharma’s latest research was recently features on news-medical.net:

A new study describes a synthetic peptide used as a platform to generate protective adaptive cellular immunity to the virus in rhesus macaques, which are the gold standard for preclinical testing …